Initial treatment of HIV infection: Randomized trials with clinical end points are still needed

被引：16

作者：

Hughes, Michael D. ^{[1
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2006年 / 194卷 / 05期

关键词：

D O I：

10.1086/506369

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：542 / 544

页数：3

共 13 条

[1]

*ANT THER COH COLL, 2006, J INFECT DIS, V194

[2]

*DHHS, 2006, GUID US ANT AG HIV 1

[3]

Gulick R, 2005, 45 INT C ANT AG CHEM

[4] Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection [J].

Gulick, RM ;

Ribaudo, HJ ;

Shikuma, CM ;

Lustgarten, S ;

Squires, KE ;

Meyer, WA ;

Acosta, EP ;

Schackman, BR ;

Pilcher, CD ;

Murphy, RL ;

Maher, WE ;

Witt, MD ;

Reichman, RC ;

Snyder, S ;

Klingman, KL ;

Kuritzkes, DR .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1850-1861

[5]

Hughes MD, 2005, STAT BIOL HEALTH, P295

[6] Randomized trials or observational tribulations? [J].

Pocock, SJ ;

Elbourne, DR .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1907-1909

[7] Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection [J].

Robbins, GK ;

De Gruttola, V ;

Shafer, RW ;

Smeaton, LM ;

Snyder, SW ;

Pettinelli, C ;

Dube, MP ;

Fischl, MA ;

Pollard, RB ;

Delapenha, R ;

Gedeon, L ;

van der Horst, C ;

Murphy, RL ;

Becker, MI ;

D'Aquila, RT ;

Vella, S ;

Merigan, TC ;

Hirsch, MS ;

Nokta, M ;

Johnson, V ;

Morse, G ;

Putnam, B ;

Klebert, M ;

Martinez, A ;

Chiesi, A ;

Tomino, C ;

Deeks, S ;

Testa, M ;

Nevin, T ;

Levin, J ;

French, V ;

Fennell, O ;

Stevens, M ;

Grosso, R ;

Dusak, B ;

Hodder, S ;

Squibb, M ;

Brothers, C ;

Tolson, J ;

Leavitt, R ;

Manion, D ;

Ruiz, N ;

Morrisey, K ;

Quart, B ;

Jennings, C ;

Dascomb, S ;

Cooper, M ;

Murphy, M ;

Blakelock, K ;

Doolan, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) :2293-2303

[8] Marginal structural models and causal inference in epidemiology [J].

Robins, JM ;

Hernán, MA ;

Brumback, B .

EPIDEMIOLOGY, 2000, 11 (05) :550-560

[9] Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].

Staszewski, S ;

Morales-Ramirez, J ;

Tashima, KT ;

Rachlis, A ;

Skiest, D ;

Stanford, J ;

Stryker, R ;

Johnson, P ;

Labriola, DF ;

Farina, D ;

Manion, DJ ;

Ruiz, NM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873

[10] Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study [J].

Sterne, JAC ;

Hernán, MA ;

Ledergerber, B ;

Tilling, K ;

Weber, R ;

Sendi, P ;

Rickenbach, M ;

Robins, JM ;

Egger, M .

LANCET, 2005, 366 (9483) :378-384

← 1 2 →